#EAU20 Virtual - Management of patients with CRPC in 2020
EAU
7/17/20, 8:00 PM
Europe/Madrid GMT+2
Description
Management of patients with CRPC in 2020
Thematic session 03
Fri 17 July
17:00 - 18:30
Location:Virtual room 1Chairs: M. De Santis, Berlin (DE)
M. Wirth, Dresden (DE)
Learning objectives
This session will review the current challenges in the management of castration resistant prostate cancer in view of novel imaging, novel therapeutics, earlier use of anticancer drugs, molecular markers and pathology. A focus will be prediction of response and sequencing of treatment options. Case based discussions will exemplify the challenges in 2020 for daily practice.
17:00 - 17:15
CRPC: Prediction of response to systemic treatment
L. Horvath, Sydney (AU)
17:15 - 17:30
Imaging of CRPC - what is possible, what is necessary?
W.L. Loidl, Linz (AT)
17:30 - 17:45
Molecular pathology before systemic treatment - what is feasible?
S. Perner, Luebeck (DE)
17:45 - 17:50
Discussion, questions and answers
M. De Santis, Berlin (DE)
M. Wirth, Dresden (DE)
17:50 - 18:15
Case-based debate M0 CRPC: Androgen Receptor Targeted Treatment (ARTA)
17:50 - 17:55
Case presentation
G. Gandaglia, Milan (IT)
17:55 - 18:05
Yes
A. Morgans, Chicago (US)
18:05 - 18:15
No
J. Bedke, Tübingen (DE)
18:15 - 18:25
The best sequence for M+ CRPC in 2020
A. Birtle, Preston (GB)
18:25 - 18:30
Discussion, questions and answers
M. De Santis, Berlin (DE)
M. Wirth, Dresden (DE)
Previous registration necessary?
NO
YES
Simultaneous translation ?
NO
YES
Will it be recorded?
NO
YES
M. De Santis, M. Wirth
CRPC: Prediction of response to systemic treatment
Inglês
Speakers
L. Horvath, W.L. Loidl, S. Perner, G. Gandaglia, A. Morgans, J. Bedke, A. Birtle
Register your event here
Already have an account? LOGIN HERE. If You don't have an account you need to create a free account.